(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 4.16% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Teleflex's revenue in 2025 is $3,010,144,000.On average, 12 Wall Street analysts forecast TFX's revenue for 2025 to be $137,273,347,036, with the lowest TFX revenue forecast at $136,398,140,000, and the highest TFX revenue forecast at $141,202,808,339. On average, 12 Wall Street analysts forecast TFX's revenue for 2026 to be $143,798,690,262, with the lowest TFX revenue forecast at $140,410,499,838, and the highest TFX revenue forecast at $160,609,726,771.
In 2027, TFX is forecast to generate $150,313,560,699 in revenue, with the lowest revenue forecast at $143,574,431,164 and the highest revenue forecast at $168,829,319,871.